Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose naloxone for prevention of acute remifentanil-induced hyperalgesia
IRCT20101122005225N8Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of naloxone in hyperalgesia, sponsored by Tehran University of Medical Sciences. Started Aug 2017; status: completed.
02
Drugs
naloxone
03
Conditions
hyperalgesia
Beyond the preview
Go deeper on IRCT20101122005225N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101122005225N8.